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Background: Remifentanil can be an alternative to N2O in general anesthesia. Intraoperative remifentanil may lead 
to acute opioid tolerance. This study aims to assess the effect of remifentanil substituted for 70% N2O on postoperative 
pain in children undergoing tonsillectomy/adenoidectomy. In addition, we evaluated the effect of remifentanil 
infusion on incidence of emergence agitation in these patients.
Methods: Eighty children, aged 2-12 years, undergoing tonsillectomy/adenoidectomy were randomly allocated 
to the N2O group (Group N; n = 40, sevoflurane and 70% N2O) or remifentanil group (Group R; n = 40, sevoflurane 
with remifentanil infusion at the rate of 0.17 μg/kg/min). In the recovery room, severity of pain and agitation were 
assessed by an investigator blinded to the assigned group. Time to eye opening and incidence of severe pain and 
agitation were compared between groups. Logistic regression was used to identify factors related to occurrence of 
severe pain and agitation. 
Results: Number of patients with severe postoperative pain was 6 and 16 in groups N and R, respectively (P = 0.012). 
Incidence of emergence agitation was not significantly different between groups. Remifentanil infusion was a 
significant factor related to the occurrence of severe postoperative pain (P = 0.015), and age was inversely related to 
occurrence of emergence agitation (P = 0.001). 
Conclusions: In children undergoing tonsillectomy/adenoidectomy, intraoperative remifentanil infusion may 
increase incidence of severe postoperative pain compared to N2O, but it may not affect incidence of emergence 
agitation. (Korean J Anesthesiol 2011; 61: 148-153)
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Introduction 
    Nitrous oxide (N2O) has been used as an anesthetic adjuvant 
during general anesthesia for centuries because of its minimum 
alveolar concentration-reducing effect, rapid offset and low 
cost. However, there are unwanted side effects such as bowel 
distension, postoperative nausea and vomiting [1]. Although 
rare, N2O has also been associated with serious complications 
such as myelopathy, megaloblastic anemia and vitamin B12 
deficiency [2], as it inactivates vitamin B12, a key enzyme 
for methionine synthase. In addition, N2O may be harmful 
to the developing brain in animal study [3]. Therefore, other 
alternatives to N2O may be needed. 
    Remifentanil is a widely used opioid. Because of its rapid 
onset and offset, remifentanil can be an ideal substitute for 
N2O. It can be given in high doses intraoperatively without 
causing postoperative respiratory depression. However, it 
has some drawbacks such as muscle rigidity, postoperative 
nausea and vomiting and dose-dependent decreases in systolic 
blood pressure and heart rate [4]. There is some evidence that 
remifentanil increases postoperative analgesic requirement due 
to acute opioid tolerance [5,6]; however, inconsistent findings 
have been also presented [7,8]. Further studies on the effect of 
remifentanil on postoperative pain are needed. 
    Emergence agitation is a common phenomenon in pediatric 
patients anesthetized with sevoflurane, which has been the 
subject of numerous investigations [9]. The use of analgesics 
may affect the incidence of emergence agitation [10]. However, 
there is little evidence that intraoperative remifentanil may 
affect its incidence. 
    In this study we aimed to compare postoperative pain of 
sevoflurane-remifentanil anesthesia with that of sevoflurane-
N2O anesthesia in children undergoing tonsillectomy/adeno-
idectomy. Based on the previous study by Lee et al. [7], remi-
fentanil was infused at the rate of 0.17 μg/kg/min as a substitute 
for 70% N2O. We also compared the incidence of emergence 
agitation between groups. 
Materials and Methods
    After obtaining approval of the Institutional Review Board 
and informed consent from parents, 80 pediatric patients aged 
2-12 years (American Society of Anesthegiologists class I, II) 
and undergoing elective tonsillectomy/adenoidectomy were 
enrolled. Patients were excluded from the study if they had 
allergy to opioids, hepatic or renal dysfunction, neurological 
disease, psychological disease or airway problems. 
    The sample size required for a 15% difference in incidence of 
severe pain with different anesthetics was 28 patients for each 
group (for a level of significance of 0.05 and a power of 0.80). 
It was calculated based on the assumption that incidence of 
severe pain in sevoflurane- N2O group would be approximately 
20%. For a 15% difference in incidence of severe agitation, 
the sample size was calculated to be 37 for each group based 
on the assumption that incidence of severe agitation in the 
sevoflurane-N2O group would be 30% (for a level of significance 
of 0.05 and a power of 0.80) [11]. It was decided to include 40 
patients in each group.
    Patients were randomly allocated to the N2O (group N, n = 40) 
or remifentanil group (group R, n = 40). A computer generated 
random numbers table was used for randomization of group 
assignment. 
    Glycopyrrolate 0.005 mg/kg was injected intramuscularly 
as a premedication 30 minutes before anesthesia. When the 
patient arrived at the operating room, preoperative behavior 
was evaluated and categorized into one of the following: calm, 
slightly anxious, uncooperative. This was performed by an 
anesthesiologist who carried out the anesthesia of all patients 
in the study. Electrocardiography, non-invasive blood pressure 
and pulse oximetry were monitored. 
    In both groups, general anesthesia was induced with 
thiopental 5 mg/kg, rocuronium 0.6 mg/kg and 3-4 vol% 
sevoflurane in oxygen 5 L/min (FIO2 1.0). After intubation, 
group N received sevoflurane and 70% N2O for maintenance 
of anesthesia (FIO2 0.3). Group R received sevoflurane with 
remifentanil infusion at the rate of 0.17 μg/kg/min (FIO2 0.3: 
O2 0.6 L/min, medical air 4.4 L/min) for maintenance of 
anesthesia. In both groups, sevoflurane was titrated to maintain 
systolic blood pressure within 20% of pre-anesthetic values. 
    End-tidal concentrations of sevoflurane and carbon dioxide 
were continuously monitored (anesthetic Gas Module No. 
M1026B, Phillips Medical System, Best, Netherlands). End-
tidal sevoflurane concentrations were recorded at 5-minute 
intervals. From these values, the area under the sevoflurane 
concentration curve was approximated by the trapezoidal rule. 
Then, it was divided by the total anesthetic time in minutes. 
This value was regarded as the mean end-tidal sevoflurane 
concentration (Et-Sevo).
    During surgery, the surgeon infiltrated 1% lidocaine with 
epinephrine (1 : 100,000) at the operation site for bleeding and 
pain control. At the end of surgery, all anesthetics were stopped 
and neuromuscular blockade was reversed with pyridostigmine 
0.25 mg/kg and glycopyrrolate 0.005 mg/kg. The endotracheal 
tube was extubated when patients opened their eyes with 
full recovery of spontaneous breathing and adequate motor 
activity. The time to eye opening from stopping anesthetics was 
measured. After extubation, children were transferred to the 
postanesthetic care unit (PACU). 
    In the PACU, vital signs, modified Aldrete recovery score, pain 
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for 60 minutes by an anesthesiologist who was blinded to the 
assigned group and not involved in the anesthetic procedure. 
To assess postoperative pain, the Oucher scale was used, which 
is a validated and useful measure for pre-school as well as for 
primary school-aged child [12]. The Oucher scale consists of 
six gradations from 0 to 100 (0, 20, 40, 60, 80, 100). Pain was 
assessed via facial expression. A score of 0 was assigned to a 
child who was calm and complaisant, and 100 to a child in a 
state of severe distress, accompanied by constant crying and 
a grimacing expression [12]. Severe pain was defined as an 
Oucher pain score above 60. To avoid misinterpretation of 
pain level due to influence of agitation, pain scores in the first 
5 minutes of the PACU stay were omitted from the count of 
severe pain. In case of severe pain or patient’s complaint of 
pain, 0.5 μg/kg of intravenous fentanyl was administered. If 
additional pain control was required, 0.25 μg/kg of fentanyl was 
administered as necessary. 
    Emergence agitation was assessed using a 4-point scale 
[13] (1, calm; 2, not calm but could be easily calmed; 3, not 
easily calmed, moderately agitated; 4, combative, excited or 
disoriented). Severe agitation was defined as an agitation score 
3 or 4. 
    To check nausea and vomiting episodes, a 4-grade scale was 
used: grade 0 = absence of nausea and vomiting; grade 1 = 
nausea only; grade 2 = single emetic episode; grade 3 = multiple 
emetic episodes. If necessary, intravenous ondansetron 50 μg/
kg was given to treat nausea and/or vomiting. 
    Statistical analysis was performed using SPSS version 13.0 for 
Windows (SPSS Inc, USA). Data were compared between two 
groups by t-test, Mann-Whitney U test or Chi-square test, as 
appropriate. Logistic regression was used to identify significant 
variables involving occurrence of severe pain and agitation. 
Covariates in logistic regression were age, sex, weight, duration 
of operation, Et-Sevo, and group (remifentanil infusion or not). 
P < 0.05 was considered statistically significant. 
Results
    Of the 80 patients enrolled in the study, two children were 
excluded because of reoperation. Thus, data from 78 patients 
were analyzed. No significant differences were found between 
groups in terms of age, sex and height. Weight was higher 
in group N than in group R (Table 1). Preoperatively, most 
patients were calm. Two children were anxious, but they were 
also cooperative. There were no differences between groups in 
operation time, time to eye opening and time to reach discharge 
criteria (modified Aldrete recovery score of 10). The Et-Sevo was 
higher in group N than in group R (P < 0.05) (Table 2). 
    Immediately after arriving at the PACU, pain and agitation 
scores were not different between groups. More patients 
showed severe postoperative pain in group R than in group N 
(number of patients with severe postoperative pain: 6 and 16 in 
group N and R, respectively; P = 0.012). In addition, the number 
of patients receiving fentanyl in the PACU was higher in group 
R than in group N (10 and 20 in group N and R, respectively. P = 
0.020). However, there were no significant differences between 
groups in the count of fentanyl administration (0.38 ± 0.91 
and 0.59 ± 0.64 [mean ± SD] in groups N and R, respectively). 
Fentanyl dose given in the PACU did not differ significantly 
between groups (Table 3). In cases of severe pain, there was no 
difference in time to onset between groups (mean ± SD: 23.3 
± 13.3 and 18.4 ± 6.3 minutes in groups N and R, respectively). 
Incidence of severe agitation was not different between groups 
(Table 3). 
    For logistic regression, age, sex, weight, duration of operation, 
Et-Sevo and group (remifentanil infusion or not) were included 
as covariates. In univariate and multivariate logistic regression, 
group was the only covariate associated with severe pain (P = 
0.015). Severe agitation was significantly related with age (P = 
0.001), weight (P = 0.003), and Et-Sevo (P = 0.049) in univariate 
Table 1. Demographic Data
Group N (n = 39) Group R (n = 39)
Age (year)
Sex (Male/Female)
Weight (kg)
Height (cm)
6.8 ± 2.3
25/14
29.1 ± 11.0
123.7 ± 14.8
6.3 ± 2.1
24/15
24.9 ± 7.2*
120.5 ± 12.9
Values are mean ± SD or number of patients. Group N: nitrous oxide 
group, Group R: remifentanil group. *P < 0.05 compared to group N.
Table 2. Mean Sevoflurane Concentration, Surgical and Recovery Durations 
Group N (n = 39) Group R (n = 39)
Et-Sevo (vol%)
Duration of operation (min)
Time to eye opening from stopping anesthetics (min)
Time to reach discharge criteria since arriving at PACU (min)
1.63 ± 0.20
40.7 ± 20.4
10.7 ± 2.4
12.2 ± 12.5
1.45 ± 0.21*
42.5 ± 18.7
10.9 ± 2.5
13.1 ± 15.9
Values are mean ± SD or number of patients. Group N: nitrous oxide group, Group R: remifentanil group. Et-Sevo: mean end-tidal sevoflurane 
concentration during anesthesia. Discharge criteria: modified Aldrete recovery score of 10. PACU: postanesthetic care unit. *P < 0.05 compared 
to group N.151 www.ekja.org
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analysis. However, in multivariate analysis, only age remained 
significant.
    The following equations were obtained from logistic 
regression with forward stepwise (Wald) for severe pain and 
agitation.
    
     = H
SDLQ VHYHUH 3
 
   


  
    Z = -3.047 + 1.342 × remifentanil infusion (P = 0.015)
    Odds ratio (95% Confidence interval) for remifentanil infusion 
group: 3.826 (1.301 - 11.253).
    
= H
DJLWDWLRQ VHYHUH 3
 
   


   
    Z = 3.161 - 0.537 × age (P = 0.001)
    Odds ratio (95% Confidence interval) for increasing age: 0.585 
(0.429 - 0.797).
    Remifentanil infusion was a significant factor related to 
occurrence of severe postoperative pain (P = 0.015), and age was 
inversely correlated with occurrence of emergence agitation (P 
= 0.001). 
    Number of patients who experienced postoperative nausea 
and vomiting was 10 and 14 in groups N and R, respectively 
(Table 3). In each group, 5 patients were treated with ondanse-
tron 50 μg/kg. No major complications were observed in any 
patient during the study period.
Discussion 
    In the current study, 0.17 μg/kg/min of remifentanil infusion 
led to higher incidence of severe postoperative pain compared 
to 70% N2O. This finding was also supported by results of logistic 
regression analysis. 
    Increased postoperative pain in the remifentanil group may 
have been related with acute opioid tolerance. 
    Intraoperative remifentanil infusion can lead to acute opioid 
tolerance [5, 6]. Though the underlying mechanism remains 
unknown, activation of N-methyl-D-aspartate (NMDA) 
receptor function has been suggested to play important roles 
[14,15]. Opioid tolerance is known to develop very rapidly. In 
experimental pain models with volunteers receiving constant 
rate infusion of remifentanil, hyperalgesia or opioid tolerance 
was observed after a 30- to 90-min infusion [16,17]. 
    The dose of remifentanil is a factor affecting development of 
opioid tolerance. In adult patients, postoperative pain score and 
morphine consumption were higher in patients receiving a high 
dose of intraoperative remifentanil (0.3 μg/kg/min) compared 
to those receiving a low dose (0.1 μg/kg/min) [6]. In another 
study, it was demonstrated that hyperalgesia to painful pressure 
stimuli developed after high dose remifentanil (0.4 μg/kg/min) 
rather than low dose (0.1 μg/kg/min) [18]. 
    In a study by Lee et al. [7], intraoperative remifentanil infusion 
at the rate of 0.17 μg/kg/min did not induce acute opioid tole-
rance. However, the same dose of remifentanil altered post-
operative pain in the present study. The inconsistent results 
could be caused by differences in study populations, surgical 
procedures and postoperative pain management between the 
two studies. In addition, the actual infusion schemes were not 
the same. While remifentanil was infused at a fixed rate in our 
study, variable infusion rates were used in the other study and 
mean infusion rate was calculated later. 
    Incidence of severe pain and number of patients receiving 
fentanyl in the PACU were higher in the remifentanil group. 
However, fentanyl doses in the PACU were not significantly 
different between groups in the current study. This discrepancy 
seems to originate from variability in total fentanyl doses among 
Table 3. Postoperative Profiles
Group N (n = 39) Group R (n = 39)
Pain score at PACU arrival
Agitation score at PACU arrival
Number of patients with severe pain at PACU
Number of patients with severe agitation at PACU
Total number of patients with PONV at PACU 
    Grade 1
    Grade 2
    Grade 3
Number of patients receiving fentanyl in PACU
Fentanyl dose at PACU (μg/kg)
50 (10-70)
2 (1-4)
6
16
10
5
3
2
10
0.17 ± 0.35
60 (10-80)
2 (1-4)
16*
19
14
7
4
3
20
†
0.28 ± 0.28
Agitation and pain scores are described as median (range) of values obtained in 60 minutes. Fentanyl dose is mean ± SD. Other values are 
number of patients. Group N: nitrous oxide group, Group R: remifentanil group. PACU: postanesthetic care unit, PONV: postoperative nausea 
and vomiting. Severe agitation is defined as agitation score 3 or 4. Agitation score 3 means patient is not easily calmed score 4 is combative, 
excited or disoriented. Severe pain was defined as Oucher pain score above 60. To avoid misinterpretation of pain level due to influence of 
agitation, pain scores of first 5 minutes in PACU were omitted from severe pain count. *P = 0.012 compared to group N, 
†P = 0.020 compared to 
group N.152 www.ekja.org
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children. Since in some patients fentanyl was given more than 
once (initially 50 μg/kg then additional 25 μg/kg if needed), the 
total fentanyl doses were variable among patients. 
    In some studies, intraoperative infiltration of local anesthetics 
to the surgical field and/or non-steroidal anti-inflammatory 
drugs provided adequate postoperative analgesia [19,20]. In the 
present study with intraoperative injection of local anesthetics, 
56 children (71.8%) did not complain of severe pain in the 
PACU.
    Emergence agitation is a common phenomenon in pediatric 
patients after anesthesia. It is known to be affected by type 
of anesthetic, age, gender, previous surgery, preoperative 
anxiety, adaptability, type of surgery (especially ophthalmology 
and otorhinolaryngology procedures), analgesics, and time 
to awakening [21,22]. Incidence of emergence agitation in 
pediatric patients after sevoflurane anesthesia has been 
reported to be about 33-80% [23,24]. In children aged 3-9 
years undergoing strabismus surgery, incidence of emergence 
agitation assessed by a 4-point scale was 35% in the sevoflurane 
group [23]. In a study by Cravero et al. [24], emergence agitation 
was measured based on two different criteria in children 
scheduled for magnetic resonance imaging. In the study, when 
high threshold criteria (level 5, thrashing behavior requiring 
restraint) were applied, the incidence after sevoflurane anesthesia 
was 33%. However, with lower threshold (level 4, crying) 
criteria, incidence was 80% in the same group of children. 
    In the present study, incidence of severe emergence agitation 
was 44.9% in total. No difference was found between groups 
(41.0% and 48.7% in groups N and R, respectively). Rapid 
awakening after use of insoluble anesthetics may initiate 
emergence agitation by worsening underlying apprehension 
in children [25]. Even though remifentanil has the same charac-
teristics (rapid awakening), there is no evidence that remi  fentanil 
can cause emergence agitation. From the logistic regression 
of this study, remifentanil infusion was not associated with 
increased incidence of severe agitation. However, age was 
inversely related to probability of emergence agitation, which is 
consistent with a previous study [26]. 
    In this study, we considered remifentanil infusion at the rate 
of 0.17 μg/kg/min to be equipotent to 70% N2O based on the 
previous findings of Lee et al. [7], which were obtained from 
adult patients undergoing colorectal surgery. However, in the 
present study, patients in group R consumed less sevoflurane 
than those in group N by 11% (Table 2), which suggests the 
equipotent dose of remifentanil to 70% N2O may be slightly less 
than 0.17 μg/kg/min. Mathews et al. [27] reported that 66% N2O 
may be replaced by a remifentanil bolus 0.7 μg/kg followed 
by infusion of 0.085 μg/kg/min, which corresponds to 2 ng/
ml of remifentanil blood concentration in adult patients for 
ambulatory orthopedic surgery. Dissimilarities among studies 
in the way of assessing anesthetic depth and type of surgery 
seem to be the main causes of inconsistent findings. It has been 
reported that clearance of remifentanil is higher in children 
compared to adults [28]. Therefore, pharmacokinetic differences 
between adults and children might be another factor causing 
the inconsistencies between this study and others. 
    Even though Et-Sevo was slightly higher in group N, no 
difference was observed between groups in recovery indices 
such as time to eye opening and time to reach discharge criteria. 
The 50% washout time of sevoflurane is less than 5 minutes [29]. 
Therefore, it is less likely that the difference in Et-Sevo affects 
altered incidence of severe postoperative pain between groups. 
    There were some limitations in the present study. Since 
lidocaine infiltration was done by a surgeon, the amount of 
lidocaine was not controlled. This might affect the severity of 
postoperative pain because lidocaine infiltration was the only 
measure for postoperative analgesia. Using established protocol 
of local infiltration or intraoperative analgesics might eliminate 
this potential problem. Another limitation was the lack of 
objective measure such as bispectral index in assessing depth of 
anesthesia. Even though we assessed the analgesic component 
of anesthesia based on vital signs, additional usage of bispectral 
index could be helpful for titrating sevoflurane concentrations 
and for confirming the equipotent dose of remifentanil to 70% 
N2O. 
    In conclusion, in children undergoing tonsillectomy/
adenoidectomy, intraoperative remifentanil infusion may 
increase incidence of severe postoperative pain compared to 
70% N2O. However, incidence of severe emergence agitation 
did not change when substituting intraoperative remifentanil 
infusion for N2O. 
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